Immediate Versus Later Insertion of IUD After Medical Termination of Pregnancy
1 other identifier
interventional
264
1 country
1
Brief Summary
The main objective of this study is to compare, in a randomised, controlled and prospective fashion, initiation of intrauterine contraception (IUC) at about immediate (0 to 3 days) versus 2 to 4 weeks post medical abortion with regard to expulsions and use of contraception one year after abortion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2012
CompletedFirst Posted
Study publicly available on registry
December 24, 2012
CompletedStudy Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedMarch 7, 2019
March 1, 2019
5.9 years
December 13, 2012
March 4, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of expulsions
Number of IUD expulsions
1 year
Use of IUD
1 year
Secondary Outcomes (2)
Bleeding profile
3 months
Repeat abortions
5 years
Study Arms (2)
Control group
NO INTERVENTIONInsertion of IUD at 2-4 weeks after abortion.
Immediate IUD insertion
EXPERIMENTALInsertion of IUD immediately (at the same day to 3 days) after expulsion of placenta.
Interventions
Insertion of LNG-IUD (Mirena) (at the same day to 3 days) after expulsion of placenta.
Eligibility Criteria
You may qualify if:
- Age ≥18 years
- Planning medical abortion
- Planning LNG-IUD (Mirena) contraception
You may not qualify if:
- Pathological pregnancies or abnormality of the uterus or cervix
- Acute endometritis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Riina Korjamolead
Study Sites (1)
Helsinki University Central Hospital, Dept Ob&Gyn
Helsinki, Finland
Study Officials
- STUDY DIRECTOR
Oskari Heikinheimo, MD, PhD
Helsinki University Central Hospital
- PRINCIPAL INVESTIGATOR
Maarit Mentula, MD, PhD
Helsinki University Central Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
December 13, 2012
First Posted
December 24, 2012
Study Start
January 1, 2013
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
March 7, 2019
Record last verified: 2019-03